AP2A1 and familial pancreatic carcinoma: For example, circEIF3I may act as a molecular scaffold, interacting with SMAD3 and AP2A1 to form a complex that facilitates SMAD3 transport to early endosomes, activating downstream TGF-β signaling and promoting pancreatic cancer progression [29].